477. Phase I Safety and Immunogenicity of HPV 16 and 18 DNA Vaccines Delivered via Electroporation

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)37918-7
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy